Construction and biological activity of metallothionein fused with ELP.
- Author:
Longying LIU
1
;
Tingting WANG
1
;
Wei YU
1
;
Simeng XU
1
;
Xianlong YE
1
Author Information
- Publication Type:Journal Article
- Keywords: biological activity; elastin-like polypeptides (ELPs); metallothionein (MT); purification by inverse transition cycling (ITC); soluble expression
- MeSH: Metallothionein/metabolism*; Elastin/chemistry*; Recombinant Fusion Proteins/pharmacology*; Mice; Animals; Peptides/metabolism*; Escherichia coli/metabolism*; NIH 3T3 Cells
- From: Chinese Journal of Biotechnology 2024;40(11):4242-4253
- CountryChina
- Language:Chinese
- Abstract: Metallothionein (MT) plays a significant role in heavy metal removal, antioxidant defense, and immune regulation. The current predominant approach for obtaining natural MT is extraction from tissue, which often entails complex procedures resulting in limited yields. In recent years, researchers have adopted the strategy of fusing labels such as GST or His for the heterologous expression of MT. However, a challenge in industrial production arises from the subsequent removal of these labels, which often leads to a significant reduction in the yield. The fusion with elastin-like polypeptides (ELPs) offers a promising solution for achieving soluble expression of the target protein, while providing a simple and fast purification process. In this study, ELP was fused with MT, which significantly up-regulated the soluble expression of MT. The fusion protein ELP-MT with the purity above 97% was obtained efficiently and simply by inverse transition cycling (ITC). ELP-MT exhibited a remarkable 2,2'-azinobis(3-ethylbenzothiazoline-6- sulfonic acid) ammonium salt (ABTS) scavenging activity, with the half maximal inhibitory concentration (IC50) of 0.77 μmol/L, which was 53.7 times that of the vitamin E derivative Trolox. In addition, the fusion protein demonstrated strong 1,1-diphenyl-2-trinitrohydrazine (DPPH) scavenging ability. Furthermore, ELP-MT had no toxicity to the proliferation and promoted the adhesion and migration of NIH/3T3 cells. All these results indicated that ELP-MT had good biocompatibility. We constructed the fusion protein ELP-MT combining the unique properties of MT and elastin, laying a technical foundation for the large-scale production of recombinant MT and facilitating the applications in food, health supplement, and cosmetic industries.
